Listen to this article The basics: Novartis plans $70M radioligand therapy manufacturing facility in Winter Park, Fla. 35,000-sf site will mark company’s 4th US RLT facility…
Listen to this article The basics: FDA approves Novartis‘ Itvisma as first gene replacement therapy for SMA patients age 2+ Treatment targets the SMN1 gene mutation,…
Listen to this article The basics: Novartis plans $771M manufacturing hub in North Carolina New facilities will produce biologics, sterile packaging, solid dosage forms Project expected…
Listen to this article The basics: Novartis to eliminate dozens of NJ jobs between November 2025–June 2026 Cuts follow two earlier rounds this year impacting 566…
3
4
5
